Status:
RECRUITING
Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
Lead Sponsor:
Queen's Medical Center
Collaborating Sponsors:
University of Hawaii Foundation
Conditions:
Sexually Transmitted Disease (STD)
Gonorrhea
Eligibility:
FEMALE
14+ years
Phase:
NA
Brief Summary
The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise...
Detailed Description
Study Design: This is an explorative cohort study that will assess the accessibility, feasibility, and utilization of a new intervention: at-home, self-collected STI testing at the time of medication...
Eligibility Criteria
Inclusion
- Patients of the Queen Medical Center Options Center clinic seeking telemedicine medication abortion.
- Patients for whom, according to the CDC guidelines for STI Testing11, STI testing is indicated, or patients who desire STI screening
- Age 14 and over
- Can speak and read English
- Displays capacity for informed consent
Exclusion
- Home address that is not located in the state of Hawai'i
- Incarcerated
- Unwilling to perform vaginal swab collection
Key Trial Info
Start Date :
May 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06951438
Start Date
May 22 2025
End Date
June 30 2026
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queens Medical Center, 1004 Clinic POB1
Honolulu, Hawaii, United States, 96813